There is a global urgency to develop a protective vaccine against HIV-1. Neutralizing antibodies (Nabs) can provide effective prophylaxis against HIV-1 infections. However, eliciting Nabs that are broadly cross-reactive against many antigenically diverse HIV-1 isolates has been a major challenge and it remains a critical roadblock to HIV-1 vaccine development. The primary objective of the studies being proposed is to generate novel antigens that are able to elicit such Nabs, with a long-term goal of developing a vaccine against the virus. The underlying hypothesis of this proposal is that we will be able to enhance immunogenicity of key epitopes that can elicit broadly reactive Nabs by altering the antigenic composition of HIV-1 envelope protein, as long as the immunogen is structurally intact and the epitopes are antigenically correct. To test this hypothesis, we have generated prototypic antigens based on gp41 membrane-proximal external region (MPER) and gp120 outer domain (gp120OD). Both proteins are immunogenic and can elicit Nabs against multiple primary HIV-1 isolates. Our goal is to use current and evolving understanding of biochemical, structural and immunogenic properties of the prototypic antigens to design second-generation antigens that could induce even more potent Nabs. The proposed studies are focused and hypothesis-driven, with clearly defined milestones and timelines. Successful completion of the proposed studies would represent a major advancement towards developing a protective AIDS vaccine. The proposed research Program consists of two Projects and one Core: The role of Project 1 is to design subunit envelope antigens, to produce them, and to evaluate their immunogenic properties. The role of Project 2 is to determine high-resolution structures of the antigens with a goal of facilitating the antigen design process and understanding of their immunological properties. The Administrative Core is responsible for providing the organizational management and maintaining infrastructure to support the fiscal monitoring.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-TJP-A (J1))
Program Officer
Li, Yen
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Iowa State University
Veterinary Sciences
Schools of Veterinary Medicine
United States
Zip Code
Banerjee, Saikat; Shi, Heliang; Habte, Habtom H et al. (2016) Modulating immunogenic properties of HIV-1 gp41 membrane-proximal external region by destabilizing six-helix bundle structure. Virology 490:17-26
Qin, Yali; Banerjee, Saikat; Agrawal, Aditi et al. (2015) Characterization of a Large Panel of Rabbit Monoclonal Antibodies against HIV-1 gp120 and Isolation of Novel Neutralizing Antibodies against the V3 Loop. PLoS One 10:e0128823
Habte, Habtom H; Banerjee, Saikat; Shi, Heliang et al. (2015) Immunogenic properties of a trimeric gp41-based immunogen containing an exposed membrane-proximal external region. Virology 486:187-97
Qin, Yali; Shi, Heliang; Banerjee, Saikat et al. (2014) Detailed characterization of antibody responses against HIV-1 group M consensus gp120 in rabbits. Retrovirology 11:125
Qin, Yali; Banasik, Marisa; Kim, SoonJeung et al. (2014) Eliciting neutralizing antibodies with gp120 outer domain constructs based on M-group consensus sequence. Virology 462-463:363-76
Hioe, Catarina E; Tuen, Michael; Vasiliver-Shamis, Gaia et al. (2011) HIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting leukotoxin (LtxA). PLoS One 6:e23202
Shi, Wuxian; Bohon, Jen; Han, Dong P et al. (2010) Structural characterization of HIV gp41 with the membrane-proximal external region. J Biol Chem 285:24290-8
Wang, Liwen; Qin, Yali; Ilchenko, Serguei et al. (2010) Structural analysis of a highly glycosylated and unliganded gp120-based antigen using mass spectrometry. Biochemistry 49:9032-45